APOZA Ozone DTA
APOZA Ozone DTA is a home CPAP/BPAP ozone disinfector (FDA Class I; FDA product code LRJ, Disinfectant, Medical Devices) made by Apoza Enterprise Co., Ltd., listed in FDA GUDID since 26 Jun 2023 (UDI-DI 04719883750822), registry data as of 23 Oct 2026.
Listed
Valid until
Not applicable
FDA recalls
Not checked
Documents
None
Trust
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | GUDID listing | Number04719883750822 | Date26 Jun 2023 | StatusListed |
Official records
- AccessGUDID record 04719883750822
From the FDA record
- MRI safety
- Labeling does not contain MRI Safety Information
- Natural rubber latex
- No latex statement on the label
- Sterility
- Supplied non-sterile; sterilise before use (Moist Heat or Steam Sterilization)
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — GUDID listing Listed
Specification
- Trade name
- Apoza
- Generic name
- Home CPAP/BPAP ozone disinfector
- Model / reference
- Ozone DTA
- Primary DI / UDI-DI
- 04719883750822
- FDA product code
- LRJ
- GMDN term
- Home CPAP/BPAP ozone disinfector
- Device class
- Class I
- Regulation number
- 880.6890
- GUDID distribution status
- In Commercial Distribution
- Sterilisation method
- Moist Heat or Steam Sterilization
Similar devices
Other devices filed under FDA product code LRJ (Disinfectant, Medical Devices).
- ASCEND GENERAL PURPOSE DISINFECTANT by Huntington Laboratories, Inc.
- EXSPOR by Alcide Corp.
- FORMULATION HWS-128 EPA REG. NO. 47371-130 by Huntington Laboratories, Inc.
- CIDE-SWIPES P-100B & CIDE-SWIPES C-100A by Mp Scientific, Inc.
- HOSPITAL BROAD BAND CLEANDR - DISINFECTANT-DEODORANT by Clariant Corporation
- CITRACE HOSPITAL GERMICIDAL DEODORIZER by Caltech Industries, Inc.
- CAVICIDE SURFACE DISINFECTANT/DECONTAMINANT CLEANER by Micro-Aseptic Products, Inc.
- LYSOL I.C. BRAND INSTRUMENT DISINFECTANT PRESOAK by National Laboratories
- CIDEX PLUS 28 DAY SOLUTION by Johnson & Johnson Medical, Inc.
- KLEENASEPTIC by METREX RESEARCH